Skip to main content

Table 3 Unadjusted cox proportional hazard model for blip participants compared to controls

From: Factors associated with HIV viral load “blips” and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case–control study

 

Blip group

N (%) or mean (SD)

Control group

N (%) or mean (SD)

Univariate hazard ratio (95 % CI)

P value

Number, n

99

673

  

Demographics

Mean age at ART (years)

34.4 (14.9)

32.9 (13.4)

1.00 (0.98,1.02)

0.9756

Mean age at HIV diagnosis (years)

29.8 (12.4)

29.1 (12.8)

1.00 (0.98,1.02)

0.7467

Gender

 Male

94 (94.9)

630 (93.6)

Ref

 

 Female

5 (5.1)

43 (6.4)

0.66 (0.27,1.63)

0.3735

Race

 Caucasian

38 (38.4)

267 (39.7)

Ref

 

 African-American

49 (49.5)

278 (41.3)

1.22 (0.80,1.86)

0.3632

 Other

12 (12.1)

128 (19.0)

0.73 (0.38,1.39)

0.3332

Time from HIV negative to seroconversion (years)

0.7 (0.6)

0.6 (0.6)

1.24 (1.04,1.49)

0.0186

Time from seroconversion to first ART (years)

1.7 (2.8)

1.7 (2.5)

1.02 (0.95,1.11)

0.536

Viral load at HIV diagnosis (log10copies/mL)

4.6 (0.9)

4.4 (1.0)

1.32 (0.99,1.76)

0.0577

Viral load at ART initiation (log10copies/mL)

4.8 (0.9)

4.5 (1.0)

1.45 (1.11,1.89)

0.0064

Viral load at ART Initiation

69,368 (115,313)

32,281 (86,112)

1.00 (1.00,1.00)

0.3596

CD4 cell count at HIV diagnosis (cells/mL)

432 (308)

439 (265)

1.00 (1.00,1.00)

0.2717

CD4 cell count at HIV diagnosis (cells/mL)

 <350

33 (36.3)

181 (29.9)

Ref

 

 350 to <500

25 (27.5)

188 (31.1)

0.74 (0.44,1.24)

0.2563

 ≥500

33 (36.3)

236 (39.0)

0.78 (0.48,1.27)

0.3223

CD4 cell count at ART initiation (cells/mL)

284 (190)

353 (189)

1.00 (1.00,1.00)

0.0553

CD4 cell count at ART initiation (cells/mL)

 <350

64 (68.1)

305 (49.7)

Ref

 

 350 to <500

22 (23.4)

190 (30.9)

0.61 (0.38,0.99)

0.0472

 ≥500

8 (8.5)

119 (19.4)

0.39 (0.19, 0.82)

0.0131

HIV medication adherence history

Self-reported antiretroviral drug adherence (%)

 ≥85

96 (98.0)

637 (96.2)

Ref

 

 <85

2 (2.0)

25 (3.8)

0.52 (0.13, 2.10)

0.358

Self-reported last time missed a dose

 Last week

16 (16.3)

98 (14.8)

Ref

 

 Longer than last week

82 (83.7)

563 (85.2)

0.88 (0.52,1.51)

0.6532

Self-reported missed a dose in the last weekend

 Yes

3 (3.1)

45 (6.8)

Ref

 

 No

95 (96.9)

612 (93.2)

0.44 (0.14,1.40)

0.166

Self-reported total missed doses in the last 2 weeks

 0

80 (81.6)

529 (80.0)

Ref

 

 1 or more

18 (18.4)

126 (19.1)

0.94 (0.56,1.57)

0.809

 All

0 (0.0)

4 (0.6)

  

 Don’t know

0 (0.0)

2 (0.3)

  
  1. Data expressed as N (%) or mean (SD)
  2. ART antiretroviral therapy